Sage Journals: Discover world-class research

Abstract

Purpose

Outline steps taken at a university teaching health system to meet The Joint Commission's (TJC's) National Patient Safety Goal (NPSG) for anticoagulation therapy.

Description

The aim of NPSG 3E (recently renumbered as 03.05.01) was to reduce the likelihood of patient harm associated with anticoagulation therapy. Full implementation of a management program for individualization of patient care was required by January 1, 2009. University Health System (UHS) has formed an anticoagulation safety committee consisting of nurses, dieticians, pharmacists, and physicians. Monthly meetings are held to assign projects and responsibilities and to report progress of ongoing tasks. Subcommittees involving selected members have been formed to conduct in-depth evaluations of specific agenda items. The committee has defined target anticoagulants, including unfractionated heparin, enoxaparin, dalteparin, argatroban, lepirudin, fondaparinux, and warfarin. Current practice has been evaluated by gathering baseline adverse events data, performing drug utilization reviews, and analyzing usage. A timeline of progress and expected completion dates for each milestone has been created. Future tasks include developing standard protocols for all anticoagulants and ensuring consistency in discharge counseling. Recently, UHS created a new anticoagulation clinical pharmacist position, and a long-term goal is creation of an anticoagulation team. Responsibilities of this team will include therapy management, discharge counseling, staff education, and maintenance of evidence-based protocols.

Conclusion

Implementing a program of this caliber to meet TJC's January 2009 deadline for full implementation of a management program posed a challenge to this large teaching institution. This article outlines the steps necessary for ensuring achievement of milestone deadlines.

Keywords

anticoagulation anticoagulation committee anticoagulation management program National Patient Safety Goal 3E

Get full access to this article

View all access options for this article.

References

The Joint Commission. 2009 national patient safety goals—renumbering program: hospital. http://www.jointcommission.org/NR/rdonlyres/9FB72FBB-431A-4E88-BA5E-09A187EC9862/0/09_NPSG_Renumbering_HAP.pdf. Accessed October 31, 2008.

The Joint Commission. National patient safety goals: facts about the national patient safety goals. http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/npsg_facts.htm. Updated August 2009. Accessed August 11, 2009.

The Joint Commission. 2009 national patient safety goals: hospital program. http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/09_hap_npsgs.htm. Updated October 31, 2008. Accessed April 30, 2008.

Gulseth

Managing Anticoagulation Patients in the Hospital: The Inpatient Anticoagulation Service. Bethesda, MD: American Society of Health-System Pharmacists; 2007; 7–15.

Dager

W.E.

, Branch

J.M.

, King

J.H.

Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacotherapy. 2000; 34(5): 567–572.

Bond

C.A.

, Raehl

C.L.

Pharmacistprovided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy. 2004; 24(8): 953–963.